Joseph Paul Eder

Dr. Eder is Chief Medical Officer at Parthenon, bringing over 30 years of clinical experience at leading cancer research institutions as well as the pharmaceutical industry. Most recently, Dr. Eder was the Clinical Director of the Early Drug Development Program as well as a Professor at the Yale School of Medicine. From 2010 to 2012, Dr. Eder was Medical Science Director, Disease Area Clinical Expert, Hematology, AstraZeneca, PLC as well as Associate Clinical Professor, Harvard Medical School, Boston, MA. Dr. Eder was Clinical Discovery Sr. Director, Oncology, AstraZeneca, PLC from 2009 to 2012, prior to which he was Medical Science Director at AstraZeneca. From 2005 to 2010, Dr. Eder was Associate Professor, at Harvard Medical School, and from 2003 to 2007 was Clinical Director at, Clinical Research Center at the Dana-Farber Cancer Institute. He was Clinical Director, Experimental Therapeutics & Translational Pharmacology, at Dana-Farber Harvard Cancer Center from 1998 to 2007, and was Assistant Professor, at Harvard Medical School from 1988 to 2004. From 1985 to 1988 Dr. Eder was Instructor, at Harvard Medical School. Dr. Eder was awarded his MD from Georgetown University School of Medicine.